Dr. Schaefer-Cutillo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1503B N Road St
Elizabeth City, NC 27909Phone+1 252-331-2044
Education & Training
University of RochesterFellowship, Hematology and Medical Oncology, 2006 - 2009
Yale-New Haven Medical CenterResidency, Internal Medicine, 2003 - 2006
State University of New York Downstate Medical Center College of MedicineClass of 2003
Certifications & Licensure
VA State Medical License 2022 - 2026
NC State Medical License 2022 - 2025
NY State Medical License 2009 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 20 citationsMild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.David J. Araten, H. Michael Belmont, Julia Schaefer-Cutillo, Arjun Iyengar, Aprajita Mattoo
The American Journal of Case Reports. 2020-09-12 - 14 citationsSyk inhibition with fostamatinib leads to transitional B lymphocyte depletionPaul M. Barr, Chungwen Wei, James Roger, Julia Schaefer-Cutillo, Jennifer L. Kelly
Clinical Immunology. 2012-03-01 - 599 citationsInhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemiaJonathan W. Friedberg, Jeff P. Sharman, John Sweetenham, Patrick B. Johnston, Julie M. Vose
Blood. 2010-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
